Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
days to go:
Expired
investment:
£894,056
Kestrl is a mobile app based on the principles of Islamic banking. It aims to cater to the over 1.9 million British Muslim community to invest in the UK in line with their religious beliefs. Consumers can avail a host of financial services from finding interest-free savings accounts to taking out a mortgage. The company raised a £135,000 pre-seed round from C-level Islamic banking professionals in January 2020. It also launched its application on Google Playstore and App store in September 2020. Kestrl is working on launching an equity-based home purchase product soon. It also aspires to expand to Malaysia/Indonesia by white labelling with established retail banks and utilising its 'inside knowledge' of the region. It will use 39% of the investment towards platform up-gradation and tech team expansion, 20% towards hiring personnel across various departments, 19% for maintaining agency license fees and acquiring its own regulatory permissions, 8% in marketing, and 14% towards ancillary costs.
days to go:
Expired
investment:
£194,502
Payment fraud and identity verification are real threats to businesses and customers, but Fingopay has developed a solution. A highly secure biometric reader that scans a person's unique finger vein to complete transactions in seconds. Customer details are stored in the cloud and can be used to offer promotions and deals. Successful pilots have been achieved in Brunel University, Copenhagen Business School and Proud Bar in Camden. Fingopay has partnerships with VISA, Worldpay and Nets.
days to go:
Expired
investment:
£1,216,240
Husky is the UK’s only open, SaaS platform for workplace pensions. For employers, the platform deals with legal and compliance burdens of auto-enrolment while helping reduce pension costs. For individuals and company directors, the app is instrumental in bringing profitable and responsible investments with the Husky for Everyone app. And for advisers and accountants, it ensures strong client relationships amidst transparency and efficiency. Close to 1.4 million employers & 22.6 million workers are affected by the UK’s automatic enrolment (AE) legislation. Within this market, a conservative estimate of fees charged on employees by pension providers is £2 billion a year; Husky aims to disrupt this market & is ready to scale. Its method of operation has led to it achieving important milestones. With more than 1000 firms onboarded, a 92% renewal rate, and an average annual fee of £438, Husky charges its onboarded firms (including Crowdcube) with monthly recurring fees laid out as part of a 3-year subscription model. With the funds received, the company aims to disrupt the relatively stagnant workplace pensions industry with innovative products and empower its customers.
days to go:
Expired
investment:
£417,338
PayRue is a London based cryptocurrency wallet. It offers an application that enables people to exchange, store, and transfer cryptocurrency in a hassle freeway. PayRue has grown its user base over 22k registered users. Its application is live on Android, Web app, and iOS. PayRue is regulated for Digital Wallet services and Crypto exchange. It is offering exchange services of ETH, BTC, Propel, XLM, and USDC. The company is planning to allocate 40% of the invested funds for product development, 40% for marketing and 20% for admin.
days to go:
Expired
investment:
£118,098
